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The objective of the study was to demonstrate the mRNA
expression of estrogen receptor      (ER    ), ER    , and pro-
gesterone receptor (PR) by block reverse transcrip-
tion–polymerase chain reaction(RT-PCR) and real-time
RT-PCR (LightCycler) in bovine ovarian follicles and
in corpus luteum during the estrous cycle and preg-
nancy. The mRNA expression of ER     and ER     mRNA
in theca interna tissue (TI) (lower pg/µg RNA) increased
continuously and significantly during final growth of
follicles, with much higher levels for ER    . The mRNA
expression of ER     and ER     in granulosa cells (GC) (fg/
µg RNA) increased continuously during follicle growth
but without any significant change. The expression of
mRNA for PR in follicles (lower fg/µg RNA) increased
continuously to maximum level in preovulatory folli-
cles with a significant change only in TI. The highest
mRNA expression for ER     (fg/µg RNA) was detected
in corpus luteum (CL) during the early luteal phase, fol-
lowing by a significant decrease of expression during
the mid, late, and regression phases. In contrast, ER    
mRNA expression is relatively high during the early
stage, decreased during the late early and mid luteal
phase, and increased significantly again during the
late luteal phase and after CL regression. During preg-
nancy (>3 mo), low levels of ER     and ER     mRNA expres-
sion (<25 fg/µg RNA) with no significant changes were
measured. No significant change in PR mRNA expres-
sion (levels <13 fg/µg RNA) during the estrous cycle and
pregnancy in bovine CL were found. The results sug-
gest an autocrine/paracrine role of steroid receptors in
the regulation of final follicle growth and corpus luteum
formation and function.
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Introduction
The ovarian steroid hormones estrogen (E) and proges-
terone (P) fulfill a number of important functions related to
reproduction by endocrine mechanisms of action. In addi-
tion to acting as hormones on structures remote from the
ovary, the steroids produced by follicle or corpus luteum
cells also act locally within the follicles or corpora lutea as
paracrine/autocrine agents, acting on or within the cells in
which they are produced (1).
The genomic effects of E and P are mediated through inter-
action with specific intracellular receptors that are mem-
bers of the nuclear receptor family. Binding of the steroids
to their receptors induces structural and functional changes
in receptor structure that culminate in an association of ligand–
receptor complexes with specific target genes to regulate their
transcription (1). Cloning and sequencing of estrogen recep-
tor  (ER) in humans (2), rat (3), and mouse (4) has pro-
vided the first example of an ER existing in two isoforms,
each of which is encoded by a separate gene. The ER pro-
tein is smaller than the previously identified ER (5,6), but
it possesses the modular structure of distinct functional
domains (A–F) characteristic for members of the nuclear
receptors. The DNA-binding domain of ER and ER is
highly conserved over several species (>95% homology in
Homo sapiens, Rattus norwegicus, Mus musculus, Bos taurus)
and the ligand-binding domains show approx 60% conserved
residues (7–9). To act on specific cell types in the ovary,
ovarian estrogen receptors must be present to induce gene
activation (genomic actions). Some studies also indicate that
estrogen receptors reside on the plasma membrane and
modulate cellular activity without directly associating with
DNA (nongenomic actions). ER and ER tissue distribu-
tions and relative levels of expression are quite different
because various tissue express either one or both receptors
(10). Most tissue of reproductive organs in rat express both
ER and ER (11,12) and the relative expression levels of
these receptors may play a major role in mediating E actions
in a particular tissue.
In contrast to E, receptors for P are expressed as two pro-
tein isoforms, PR-A and PR-B, that arise from a single gene
(13). Both isoforms of PR are expressed in a number of
vertebrate species, including rodents (14) and humans (15),
and the ratios of the individual isoforms vary in reproduc-
tive tissue as a consequence of developmental (14) and hor-
monal status (16). Although the physiological significance
of these variations is unknown, the conservation of these
two receptor isoforms and the elaborate genomic mech-
anisms for their generation suggest that their differential
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expression may be crucial for the appropriate cellular re-
sponses to P (17). Corresponding PR isoforms are not yet
demonstrated in large domestic animals.
In the ovary of domestic animals, ER and ER expres-
sion were demonstrated in bovine, sheep, and pig follicles (9,
18–20) and corpora lutea (20–22). The expression of PR was
proved in humans (23,24), mouse (25) and rat (26), as well
as in bovine and sheep follicular and luteal tissue (27–30).
However, limited information exists about quantification
and temporal changes of ER, ER and PR mRNA expres-
sion during final follicle growth, corpus luteum (CL) devel-
opment, and function during the estrous cycle and pregnancy
in the bovine ovary. The aim of the present study was to eval-
uate the expression pattern of mRNA for ER, ER, and
PR by sensitive, quantitative and reliable real-time reverse
transcription–polymerase chain reaction (RT-PCR) (31,32)
in bovine antral follicles during final growth to the preovu-
latory stage and in luteal tissue by collection of CL from dif-
ferent stages during the estrous cycle and pregnancy.
Results
Confirmation of Primer
Specificity and Sequence Analysis
For exact length verification, RT-PCR products were sepa-
rated on 2% high-resolution agarose gel electrophoresis.
Amplified gradient MasterCycler and LightCycler PCR
products (Fig. 1) showed a single band and the expected
length of 234 bp for ER, 262 bp for ER, 227 bp for PR,
and 197 bp for glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). Specificity of the desired products was addition-
ally documented with the melting curve analysis of Light
Cycler Software 3.39 (Roche Diagnostics, Mannheim, Ger-
many). The melting temperature of the high specific prod-
ucts are species- and receptor-subtype-dependent between
83.0ºC and 83.3ºC for PR, 85.0ºC and 86.0ºC for ER, 88.8ºC
and 89.3ºC for ER, and 87.9ºC and 88.8ºC for GAPDH.
Sequence analysis (MWG Biotech, Ebersberg, Germany)
of cloned steroid receptor RT-PCR products from Bos taurus
showed 100% homology to the published sequences (32).
Real-Time RT-PCR Assay Validation in Ovarian Tissues
All performed real-time assays were product-specific,
and effective PCR amplification kinetic was shown by high
PCR efficiency (Table 1). Assay sensitivities were confirmed
by detection limits down to 30 attogram (ag) (less than 14 sin-
gle-stranded DNA [ssDNA] steroid receptor molecules) and
linear quantification ranges over seven orders of magni-
tude from ag to nanogram concentrations (102–109 mole-
cules per capillary). Intra-assay and interassay variation of
<19% and <30%, respectively, were determined over the
entire quantification range (31). The advantage of a high-
temperature fluorescence acquisition in the fourth segment
during the amplification program results in reliable and
sensitive ER-subtype-specific quantification with high lin-
earity (Pearson correlation coefficient; r > 0.995) over a wide
range. High- temperature fluorescence acquisition melts the
unspecific PCR products at 81ºC, 82ºC, 85ºC, and 87ºC,
respectively, eliminates the nonspecific fluorescence signal
derived from primer dimers and ensures an accurate quan-
tification of the desired products.
Tissue-Specific mRNA Expression
Bovine ER, ER, PR, and GAPDH mRNAs were ampli-
fied by conventional RT-PCR, then cloned and sequenced
(31,32). A representative example for the PCR products of
all factors in endometrium, corpora lutea, theca interna tis-
sue, and granulose cells are shown in Fig. 1. To quantify ER,
ER, and PR transcripts also in low-abundant tissue, sensi-
tive and reliable real-time RT-PCR quantification methods
were developed and validated on the LightCycler. The mRNA
expression results indicate the existence of GAPDH, ER,
ER, and PR in all investigated tissue in the bovine ovary.
In general, the mRNA expression data obtained by block
Fig. 1. Representative sample of specific RT-PCR products for
(A) ER (234 bp), (B) ER (262 bp), (C) PR (227 bp), and (D)
GAPDH (197 bp) from (1) bovine endometrium, (2) corpus
luteum, (3) theca interna, (4) granulosa cells, (5) no template
control, and (M) DNA mass ladder (100–500 bp), separated by
agarose gel electrophoresis.
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RT-PCR were confirmed by quantitative real-time RT-PCR
(LightCycler).
The mRNA expression of the housekeeping gene (GAPDH)
resulted in constant expression levels in all investigated ovar-
ian tissues. No significant differences could be determined
between groups.
The mRNA expression of both ER subtypes in follicle
increased continuously and correlates to follicle size and
estradiol-17 (E2) concentrations. In theca interna tissue,
ER and ER mRNA expression increased continuously
and significantly during final growth of follicle, with a higher
level for ER (Fig. 2A). The mRNA expression of both ER
subtypes in granulosa cells (GC) tended to increase contin-
uously during follicle growth but without any significant
change (Fig. 2B). The absolute expression level was much
lower as compared with theca interna tissue. The expres-
sion of mRNA for PR in follicle increased continuously to
a maximum level in preovulatory follicle with significant
change only in TI (Fig. 2C). Absolute concentrations (lower
fg/µg RNA level) were much lower in comparison to ER.
Estrogen receptors were differently expressed in bovine
CL (Fig. 3A,B). The highest mRNA expression for ER in
corpus luteum (Fig. 3A) was detected during the early luteal
phase, followed by a significant decrease of expression dur-
ing the mid (d 8–12), late (d 13–16), and regression phase.
In contrast, ER mRNA expression (Fig. 3B) was rela-
tively high during the early luteal phase, decreased during
the mid luteal phase (d 5–12), and increased significantly
again during the late luteal phase (d 13–16) and after CL
regression. During pregnancy low levels of ER and ER
mRNA expression (<25 fg/µg RNA) with no significant
changes were always present. No significant change in PR
mRNA expression (<13 fg/µg RNA) was found during the
estrous cycle and during pregnancy in bovine CL (Fig. 3C).
Discussion
In follicles, our results demonstrate a relative high mRNA
expression of ER and ER in theca interna tissue (pg/µg
RNA) in comparison with granulosa cells (fg/µg RNA).
Furthermore, ER is the dominating receptor in TI in con-
trast to GC, where the levels of ER and ER are similar.
It is known from literature that both estadiol-17 (E2)
and catecholestrogens can regulate the production of andro-
gen and P within bovine and pig ovaries (33–36). The theca
cells produce androgens, which are then, in general, taken
up by granulosa cells and converted by P450-aromatase to
estrogens. The data provide evidence that a local feedback
loop may exist in ovarian follicles, where androgens pro-
duced by theca cells are used as a substrate for granulosa
cell aromatization into E, which, in turn, may provide feed-
back to stimulate theca cell production of androgens (33–
38). For the full function of this feedback loop, the upreg-
ulation of ER may play an important role. As shown for
sheep myometrium and endometrium, ER is upregulated
by E2 (39). The upregulation of ER and ER mRNA in
Table 1
Characteristics and Validation
Parameters of Real-Time RT-PCR Assaysa
ER ER PR
Produce Length 234 bp 262 bp 227 bp
Detection limit 5 ag 7 ag 30 ag
Quantification limit 404 ag 24 ag 1.7 fg
Quantification range 404 ag–4.4. ng 24 ag–24.4 ng 1.7 fg–17  ng
   (test linearity) (r = 0.995) (r = 0.996) (r = 0.998)
PCR efficiency 1.81 1.82 1.94
Intraassay variation 18.7% (n = 4) 17.6% (n = 4) 5.7% (n = 4)
Interassay variation 28.6% (n = 4) 29.7% (n = 4) 25.7% (n = 4)
aIntraassay and interassay variation of real-time RT-PCR assays were
determined over the complete quantification range. Detection limit, quan-
tification limit, and variations were based on concentrations per capillary.
Fig. 2. Tissue-specific ER, ER, and PR mRNA expression
(LightCycler real-time RT-PCR) in different bovine follicle
classes: (A) ER in TI (S) and ER in TI (c); (B) ER in GC
(S) and ER in GC (c); (C) PR in TI () and PR in GC ().
Results (concentration of mRNA/µg total RNA) represent means
± SEM from 4–5 follicles/class. Different superscript letters indi-
cate significant differences between groups (p < 0.05).
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our follicles correlates quite well with increasing levels
of E in follicular fluid (FF). The expression levels for PR
increased in parallel to ERs in follicles. Progesterone in
sheep uterus antagonizes the effect of E to increase ER gene
expression and active ER synthesis in nonpregnant sheep
uterus (39). Our results suggest that progesterone and PR
may control the stimulating effect of E on the expression of
ER receptors. E2 has a direct transcriptional effect on vascu-
lar endothelial growth factor (VEGF) gene expression (40).
VEGF is known to mediate angiogenic activity in variety
of E target tissues. VEGF mRNA expression increased in
parallel with E levels in bovine FF in GC and TI (41). Part
of the ER action could be the upregulation of LH receptor
(LHR) and follicle-stimulating hormone (FSH) receptor
(FSHR) as shown for rat granulosa cells (42). An increase
of LHR mRNA in TI and FSHR, and LHR in GC were
demonstrated in the same tissue samples (41). Both ER
and ER activate transcription. They can work in opposite
directions and activate protein-1 response elements. In gen-
eral, ER is an activator and ER is an inhibitor or without
effects on activating protein-1 sites (43). The parallel increase
of ER in TI at a lower level in comparison to ER is in
accordance with this hypothesis. The expression of ER
may be controlled by ER. In GC, the mRNA expression for
ER and ER (Fig. 2B) is similar and generally on a much
lower level. ER is no longer the dominating ER. Both ER
receptors show a tendency of upregulation parallel to increas-
ing E2 levels in FF. This upregulation correlates with an
upregulation of LHR and FSHR (41).
Our results for ER and ER mRNA expression in gen-
eral agree with observations in ewe and pig (18,20,22,44).
Immunohistochemistry showed that ovine ER protein was
located in GC, the ovarian surface epithelium, and endo-
thelium. Weak immunostaining for ER was detected in
TI. Just recently, studies of ER mRNA in ewe indicate
that small follicles (3 mm) have the highest expression of
mRNA, with a decline thereafter as follicles increase in
size (18). In contrast to our follicle mRNA data, immuno-
histochemical studies (20) established the predominance of
ER over ER in pig ovary. Staining for ER was observed
in bovine GC and TI cells of small follicles, and was strong
in medium, large, and preantral follicles. Using in situ hybri-
dization and immunohistochemistry, ER mRNA and pro-
tein were demonstrated in bovine GC of antral follicles in
various stages of follicular growth (9).
Our mRNA expression data in bovine CL show clear reg-
ulatory changes during the estrous cycle for ER and ER.
In contrast, the PR appears to be nonregulated. In general,
steroid receptor expression occurs on a relative low level.
In bovine GC and in CL, ER and ER were expressed on
a similar level. Specific binding sites of E were demonstrated
in bovine CL (45), and ER and ER mRNA localization
were shown in ovine (22,44) and pig (20) corpora lutea.
The regulatory changes for ER in bovine CL suggest
biological functions. In recent studies, the mRNA for the
P-450 aromatase was presented with a clear upregulation
during the mid and late luteal phase and a positive correlation
with the mRNA upregulation of LHR (46,47). Estradiol-17
secretion was demonstrated in microdialysis (MDS) perfusat
and confirmed by high-performance liquid chromatography
(HPLC) analysis in combination with enzyme-linked immu-
nosorbent assay (ELISA) (47). In in vitro MDS studies, E2
perfusion of bovine CL from different luteal stages with dif-
ferent doses shifted from no effect (d 5–7 and 8–12) to an
inhibitory effect (d 15–18) on P secretion during the estrous
cycle. E2 at all doses tested was most stimulative on the
Fig. 3. Steroid receptor mRNA expression (LightCycler real-time
RT-PCR) in bovine CL during the estrous cycle and pregnancy:
(A) ER, (B) ER, and (C) PR. Results (concentration of mRNA/
µg total RNA) represent means ± SEM from 4–6 CLs/stage. Dif-
ferent superscript letters indicate significant differences between
groups (p < 0.05).
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release of oxytocin during d 5–7 but continuously inhibited
oxytocin release from the middle to late luteal phase of the
estrous cycle (48). In a recent in vitro study, E inhibited P pro-
duction by bovine luteal cells in a dose-dependent manner
(49). E2 seems to be less important for the local regulation
of bovine luteal function when compared with the pig (50).
The downregulation of ER and ER during the late
early and mid luteal phases may be caused by high P levels,
as shown for the bovine endometrium (51). Surprisingly,
ER is upregulated during the late luteal phase and regres-
sion, which may underline the inhibiting activity of ER
for luteal function. In contrast to the cyclic CL, the mRNA
expression for ER and ER during pregnancy is very low
and without any regulatory changes. Because of late sampl-
ing of CL graviditatis (>3 mo), the very interesting peri-
implantation period was not covered by our samples.
A recent study and a recent review demonstrate that P
affects the functionality of the bovine early CL in an auto-
crine and paracrine manner (52,53). These actions do not
seem to be reflected by expression levels of PR in our study.
In contrast, there is evidence in the bovine CL that P may
act through genomic and nongenomic (membrane) binding
sites (27,54).
In conclusion, the presented results give evidence for
the presence and possible function of ER, ER, and PR in
bovine follicle and corpus luteum. The results support the
hypothesis that ER is the dominating and positive-acting
(stimulation and mitogenic activity) factor for follicle matu-
ration and corpus luteum formation and function.
Material and Methods
Collection of Bovine Ovaries
Entire reproductive tracts from German Simmental (Fleck-
vieh) cows were collected at a local slaughterhouse within
10–20 min after slaughter and were transported on ice to
the laboratory. The stage of the estrous cycle was defined
by macroscopic observation of the ovaries (color, consis-
tency, corpus luteum stage, number and size of follicles)
and the uterus (color, consistency, and mucus) (55). Only
follicles, which appeared healthy (i.e., well vascularized and
having transparent follicular wall and fluid) and whose
diameters were >4 mm, were used. Because healthy follicles
have relatively constant P levels in FF, only follicles with P
below 100 ng/mL FF were used for the evaluation to exclude
atretic follicles.
For the RNA extraction, the follicles were taken from the
ovary. The surrounding tissue (theca externa) was removed
with forceps under a stereomicroscope. After aspiration of
FF, follicles were bisected and their inside wall was gently
scraped and flushed with Ringer’s solution (Fresenius,
Wendel, Germany) to remove the GC. A classification of
follicles into five groups (<0.5, >0.5–5, >5–20, >20–180,
>180 ng/mL) was performed according to the follicular
fluid E2 content. The corresponding size of follicles were
in the range of (1) 5–7 mm, (2) 8–10 mm, (3) 10–13 mm,
(4) 12–14 mm, and (5) >14 mm. The TI and GC pellet was
snap-frozen in liquid nitrogen and stored at –80ºC until the
RNA isolation. The FF was stored at –20ºC until a steroid
(P and E2) determination. For further characterization of
the follicle classes, mRNA expression was determined for
the FSHR and aromatase cytochrome P-450 (ARO) in GC
and LHR in theca TI and GC (40).
The corpora lutea were accordingly assigned to the fol-
lowing stages; d 1–2, 3–4, 5–7, 8–12, 13–16, >18 of the
estrous cycle (56) and of 3–4 mo and of 6–9 mo pregnancy
(the crown–rump length of the fetus was measured to evalu-
ate the stage of pregnancy). The peri-implantation period
was not covered by CL samples. Luteal tissue was frozen
in liquid nitrogen immediately after collection. Tissue was
kept frozen at –80ºC for about 4 wk until CL were processed
for molecular techniques.
Total RNA Extraction
A sample of 500 mg frozen tissue was homogenized in
4 M guanidinium thiocyanate buffer to destroy RNase activ-
ity (57). In the following steps, the Tripure protocol (Roche)
with phenol/chloroform extraction for total RNA was used.
In order to quantify the amount of total RNA extracted, the
optical density was determined with a photometer (Eppen-
dorf, Hamburg, Germany) at three different dilutions of the
final RNA preparations at 260 nm, corrected by the 320-nm
background absorption. RNA integrity was electrophoreti-
cally verified by ethidium bromide staining and by an OD260/
OD280 nm absorption ratio >1.85.
Specific Primer Design
The primers of the investigated transcripts (Table 2)
were derived from the bovine and ovine sequences for ER
(EMBL accession no. AF110402; Y18017), ER (Z49257;
AF177936), PR (Z86041; Z66555), and GAPDH (U85042;
U94889). Primer pairs were designed to produce an ER
(234 bp), ER (262 bp), PR (227 bp), and GAPDH (197 bp)
amplification product spanning two RNA-splicing sites.
PR primer was located near the 5' end of coding sequence
of mRNA and therefore cover all two receptor isoforms A
and B. Primer design and optimization was done in the high-
homology regions of the multiple alignments in regard to
primer dimer formation, self-priming formation, and pri-
mer melting temperature (HUSAR® software at DKFZ).
Reverse Transcription
Two micrograms of total RNA from the sample prepa-
ration was reverse transcribed in 40 µL as follows: M-MLV
reverse transcription (RT) buffer (Promega, Mannheim,
Germany) and 300 µM dNTPs (MBI Fermentas, Vilnius,
Lithuania) were denaturated for 5 min at 65ºC in a Master-
cycler Gradient (Eppendorf). The subsequent RT was done
at 37ºC for 60 min by adding 2.5 mM Random Hexamer
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primers (Pharmacia, Freiburg, Germany), 200 U of M-MLV
Reverse Trancriptase (Promega), and 12.5 U of RNAsin
RNase inhibitor (MBI Fermentas). The samples were then
heated for 1 min at 99ºC to terminate RT.
Optimization of Specific RT-PCR
Conditions for RT-PCRs were optimized in a gradient
cycler with regard to Taq DNA polymerase (Roche), PCR
water, pH, primers (MWG), MgCl2 (Roche) concentrations,
and various annealing temperatures. Amplification products
were separated on a 2% high-resolution NuSieve agarose
(FMC Bio Products, Rockland, MD, USA) gel electrophor-
esis and analyzed with the Image Master system (Pharma-
cia). Optimized results were transferred on the following
LightCycler PCR protocol.
Semiquantitative RT-PCR
Semiquantitative RT-PCR in a block cycler was per-
formed as described elsewhere (41). The sequences of the
primers used are shown in Table 2. Conditions for the enzy-
matic amplification were established on a gradient cycler for
all the factors studied. To confirm the integrity of the mRNA
templates and the RT-PCR protocol, the housekeeping gene
(GAPDH) as internal standard was examined in all samples.
As negative control, water was used instead of RNA for the
RT-PCR to exclude any contamination from buffers and tubes.
Full Quantitative LightCycler PCR
For the LightCycler reactions, a master mix of the fol-
lowing reaction components was prepared to the indicated
end concentration: 6.4 µL water, 1.2 µL MgCl2 (4 mM),
0.2 µL Forward Primer (0.2 µM), 0.2 µL Reverse Primer
(0.2 µM), and 1.0 µL LightCycler Fast Start DNA Master
SYBR Green I (Roche). Nine microliters of LightCycler
master mix was put into the LightCycler glass capillaries and
25 ng reverse-transcribed total RNA in 1 µL was added as
PCR template. The capillaries were closed, centrifuged in
a microcentrifuge, and placed into the LightCycler rotor
(Roche). To improve SYBR Green I® quantification a new
fourth segment with a high-temperature fluorescence acqui-
sition point was included to the amplification cycle program
(58). The following LightCycler protocol was used for
ER, ER, and PR real-time PCR: denaturation program
(95ºC for 10 min), a four-segment amplification and quan-
tification program repeated 50 times for ER (95ºC for
15 s; 64ºC for 10 s; 72ºC for 20 s; 82ºC for 5 s with a single
fluorescence acquisition point), for ER (95ºC for 15 s;
64ºC for 10 s; 72ºC for 20 s; 87ºC for 5 s with a single fluo-
rescence acquisition point), and for PR (95ºC for 15 s; 65ºC
for 10 s; 72ºC for 20 s; 81ºC for 5 s with a single fluores-
cence acquisition point), melting curve program (60–95ºC
with a heating rate of 0.1ºC/s and a continuous fluorescence
acquisition), and a final cooling program down to 40ºC.
Housekeeping Gene Expression
To confirm a constant housekeeping gene expression
level in the investigated total RNA extractions, a GAPDH
real-time RT-PCR was performed. Real-time RT-PCR was
quantified in the LightCycler with the GAPDH specific
settings (95ºC for 15 s; 58ºC for 10 s; 72ºC for 20 s; 85ºC for
5 s with a single fluorescence acquisition point) as described
in the previous subheading.
Calibration Curves
For all quantitative assays an external calibration curve
was used, based on a single-stranded DNA (ssDNA) mole-
cule calculation. ER, ER, and PR products (RT-PCR)
from Bos taurus were cloned separately in pCR4.0 (Invitro-
gen, Leek, The Netherlands) and linearized by a unique restric-
tion digest and dilutions of each plasmid preparations from
single copies ssDNA (<10 molecules = few ag per capil-
Table 2
Primer Sequences of Estrogen Receptor  (ER), Estrogen Receptor  (ER), Progesterone Receptor (PR),
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH), and Resulting Fragment Size
Fragment EMBL
Target Sequence of nucleotidea size (bp) Referenceb
ER For 5'-AGG GAA GCT CCT ATT TGC TCC-3' 234 Pfaffl et al. (31)
Rev 5'-CGG TGG ATG TGG TCC TTC TCT-3'
ER For 5'-GCT TCG TGG AGC TCA GCC TG-3' 262 Pfaffl et al. (31)
Rev 5'-AGG ATC ATG GCC TTG ACA CAG A-3'
PR For 5'-GAG AGC TCA TCA AGG CAA TTG G-3' 227 Pfaffl et al. (31)
Rev 5'-CAC CAT CCC TGC CAA TAT CTT G-3'
GAPDH For 5'- GTC TTCACTACCATGGAGAAGG-3' 197 U85042; U94889
Rev 5'- TCATGGATGACCTTGGCCAG -3'
aFor, forwards; Rev, reverse.
bEMBL accession number or reference of published sequence.
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lary) up to 1010 ssDNA molecules (ng per capillary) were
used in calibration curve (31).
Hormone Determinations
Concentrations of P and E2 were determined directly in the
FF with an enzyme immunoassay using the second antibody
technique (59,60). The intra-assay variations were 4–5% (P)
and 6-7% (E2) and the interassay variations 8–9% (P) and
9–10% (E2).
Statistical Analyses
The statistical significance of differences in mRNA
expression of examined factors was assessed by analysis of
variance, followed by Fisher’s least square difference (LSD)
as a multiple comparison test. All experimental data are
shown as the mean ± SEM.
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